,

Investigaciones Fibromialgia Colegio Americano de Reumatologia

Encuentro anual cientifico del Colegio Americano de Reumatologia Octubre-2008, San Francisco; que se va tratar sobre la fibromialgia

El próximo Octubre, exactamente del 24 al 29, San Francisco será el centro internacional de reunión de médicos, cientificos y profesionales de la salud que ha orientado su profesión hacia el campo de la reumatologia.

Entre todos los trabajos que se han presentado destaca la presentación de estudios centrados en la enfermedad de fibromialgia.

A continuación la relación de los abstracts presentados:

Monday, October 27, 9:00 AM – 11:00 AM. 1177/438 –

Patients’ Perceptions of the Meaning of the FIQ Activity Items

Amalie L. Andrew, Ketki D. Raina, Joan C. Rogers, Terence W. Starz. University of Pittsburgh, Pittsburgh, PA

Monday, October 27, 9:00 AM – 11:00 AM. 1178/439 –

Exploring the Role of Somatosensory Amplifi-cation in Fibromyalgia: Pain, Fatigue and Functioning

Afton L. Hassett 1 , Diane C. Radvanski 1 , Shantal V. Savage 1 , Leonard H. Sigal 2 . 1 UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ; 2 Bristol-Myers Squibb Company, Princeton, NJ

Monday, October 27, 9:00 AM – 11:00 AM. 1179/440

Preliminary Results from a Randomized Controlled Trial of Heart Rate Variability Biofeedback in Fibromyalgia

Afton L. Hassett 1 , Diane C. Radvanski 1 , Leonard H. Sigal 2 , Steven Buyske 3 , Naomi Schlesinger 1 , Paul M. Lehrer 1 . 1 UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ; 2 Bristol-Myers Squibb Company, Princeton, NJ; 3 Rutgers University, Piscataway, NJ

Monday, October 27, 9:00 AM – 11:00 AM. 1180/441

Perceptions of Fibromyalgia Syndrome (FMS) in Primary Care Practice

Terence Starz, Molly Vogt, Francis Solano, Margaret Moore. University of Pittsburgh Medical Center, Pittsburgh, PA

Tuesday, October 28, 9:00 AM – 11:00 AM. 1389/111

Fibromyalgia May Potentially Complicate The Assessment Of Lupus Activity Using The Bilag

Robert S. Katz 1 , Alexandra Small 2 . 1 Rush University Medical Center, Chicago, IL; 2 University of Illinois Medical School, Chicago, IL

Tuesday, October 28, 9:00 AM – 11:00 AM. 1390/112 –

Online Versus Office Participation Of Fibromyalgia Survey

Robert S. Katz 1 , Sharon Ferbert 2 , Alexandra Small 3 , Susan Shott 1 . 1 Rush University Medical Center, Chicago, IL; 2 AFFTER, Chicago, IL; 3 University of IL Medical School, Chicago, IL

Tuesday, October 28, 9:00 AM – 11:00 AM. 1391/113

Fibromyalgia: Rehearsal Counteracts the Detrimental Effects of Distraction on Memory Formation in Fibromyalgia

Robert S. Katz, Frank Leavitt. Rush University Medical Center, Chicago, IL

Tuesday, October 28, 9:00 AM – 11:00 AM. 1393/115

Do the Symptoms Of Fibromyalgia Change During Pregnancy?

Robert S. Katz 1 , Alexandra Small 2 , Sharon Ferbert 3 . 1 Rush University Medical Center, Chicago, IL; 2 University of Illinois Medical School, Chicago, IL; 3 AFFTER (Advocates for Fibromyalgia Funding, Treatment, Education and Research, Chicago, IL

Tuesday, October 28, 9:00 AM – 11:00 AM. 1394/116

Prevalence, Incidence and Predictors of Depression in Fibromyalgia

Robert S. Katz 1 , Frederick Wolfe 2 , Kaleb Michaud 3 . 1 Rush University Medical Center, Chicago, IL; 2 National Data Bank for Rheumatic Diseases, Wichita, KS; 3 University of Nebraska Medical Center, Omaha, NE
Tuesday, October 28, 9:00 AM – 11:00 AM. 1395/117

Muscle Tension is Increased in Fibromyalgia: Use of a Pressure Gauge

Rediet Kokebie, Rohit Aggarwal, Sabiha Kahn, Robert S. Katz. Rush University Medical Center, Chicago, IL

Tuesday, October 28, 9:00 AM – 11:00 AM. 1396/118

Fibromyalgia is Common in Rheumatoid Arthritis and Impacts Patient’s Pain Perception

Varun Dhir, Able Lawrence, Amita Aggarwal, Ramnath Misra. Sanjay Gandhi Post Gradute Institute of Medical Sciences, Lucknow, India

Tuesday, October 28, 9:00 AM – 11:00 AM. 1397/119

Gait regularity and Coping in Fibromyalgia patients

Bernard Auvinet, D. Chaleil, Pr, J. Cabane, Pr, A. Dumolard, Dr, P. Hatron, Pr, R. Juvin, Pr, M. Lanteri-Minet, Pr, Y. Mainguy, Dr, L. Negre-Pages, Dr, F. Pillard, Dr, D. Riviere, Pr, Y. Maugars, Pr. Hospital, Laval, France

Tuesday, October 28, 9:00 AM – 11:00 AM. 1399/121

Muscle modification in Fibromyalgic Patients revealed by Surface Electromyography (SEMG) Analyses

Laura Bazzichi 1 , Marco Dini 2 , Alessandra Rossi 3 , Silvia Corbianco 2 , Francesca De Feo 1 , Camillo Giacomelli 3 , Cristina Zirafa 1 , Bruno Rossi 2 , Stefano Bombardieri 1 . 1 Department of Internal Medicine, Division of Rheumatology, University of Pisa, Pisa, Italy; 2 Department of Neuroscience, University of Pisa, Pisa, Italy; 3 Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology University of Pisa, Pisa, Italy

Tuesday, October 28, 9:00 AM – 11:00 AM. 1400/122 –

Five Visual Analogue Scales Quantify Global Disease Severity and Identify Clinically Significant Symptoms in Fibromyalgia Syndrome

Chad S. Boomershine, Dina Titova, Cecilia P. Chung, Annette Oeser, Michael Stein. Vanderbilt University, Nashville, TN

Tuesday, October 28, 9:00 AM – 11:00 AM. 1401/123 –

Use of Short-form Center for Epidemiologic Studies Depression Scales in Fibromyalgia Patients

Chad S. Boomershine, Dina Titova, Annette Oeser, Cecilia P. Chung, Michael Stein. Vanderbilt University, Nashville, TN

Tuesday, October 28, 9:00 AM – 11:00 AM. 1402/124 –

Patterns of Healthcare Utilization and Economic Costs in Patients With Newly Diagnosed Fibromyalgia

Ariel Berger 1 , Alesia Sadosky 2 , Gergana Zlateva 2 , John Edelsberg 1 , Ellen Dukes 2 , Gerry Oster 1 . 1 Policy Analysis Inc (PAI), Brookline, MA; 2 Pfizer Inc, New York, NY

Tuesday, October 28, 9:00 AM – 11:00 AM. 1403/125

Fibromyalgia Classification: Concordance Between ACR Criteria And Classification Based On Symptoms

Ana Assumpção, Juliana F. Sauer, Suellen D. Chalot, Alane B. Cavalcante, Carlos A b Pereira, Amelia P. Marques. Universidade de São Paulo, São Paulo, Brazil

Tuesday, October 28, 9:00 AM – 11:00 AM. 1404/126 –

Factor Analysis of Fibromyalgia Tender Points: The Parts May Be as Important as the Whole

Terence W. Starz 1 , Hilary Wilson 2 , James Robinson 2 , Dennis Turk 2 . 1 Arthritis & Internal Medicine Associates-UPMC, Pittsburgh, PA; 2 University of Washington, Seattle, WA

Tuesday, October 28, 9:00 AM – 11:00 AM. 1405/127 –

Fibromyalgia: What’s Tender, What’s Not

Terence W. Starz, Molly Vogt, Kenneth Gold. University of Pittsburgh School of Medicine, Pittsburgh, PA

Tuesday, October 28, 9:00 AM – 11:00 AM. 1406/128

Comparing Practice Patterns in Fibromyalgia Syndrome (FMS): Rheumatology versus Primary Care

Terence W. Starz 1 , Molly Vogt 1 , Jennifer Keeler 2 . 1 University of Pittsburgh Medical Center, Pittsburgh, PA; 2 Pennsylvania Rheumatology Society, Harrisburg, PA

Tuesday, October 28, 9:00 AM – 11:00 AM. 1407/129

Disregulation Of Proinflammatory Cytokines In The Deltoid Muscle Of Patients With Fibromyalgia

vicente torrente-segarra, sandra mas, nuria segales, joaquim gea, esther barreiro, jordi carbonell abelló. Hospital del Mar, Barcelona, Spain

Tuesday, October 28, 9:00 AM – 11:00 AM. 1408/130

Physical Function in Fibromyalgia Patients after age 50: The Influence of Symptoms and Comorbidity

Casey R. Shillam 1 , Kim D. Jones 2 , Lois Miller 2 , Kerri Winters-Stone 2 , Robert M. Bennett 2 . 1 University of Portland, Portland, OR; 2 Oregon Health & Science University, Portland, OR

Tuesday, October 28, 9:00 AM – 11:00 AM. 1410/132

Prevalence of Fibromyalgia in Europe – A Tip of the Iceberg – Results from a large-scale survey

Jaime Branco 1 , Bernard Bannwarth 2 , I. Failde 3 , J. Abello Carbonell 4 , F. Blotman 5 , M. Spaeth 6 , F. Saraiva 7 , F. Nacci 8 , E. Thomas 5 , JP Caubère 9 , K. Le Lay 10 , C. Taieb 10 , M. Matucci Cerinic 8 . 1 Serviço de Reumatologia, CHLO, EPE/Hospital Egas Moniz, Lisbon, Portugal; 2 Université V. Segalen, Bordeaux, France; 3 3. Area de Medicina Preventiva y Salud Pública, Universidad de Cadiz, Cadiz, Spain; 4 S Reumatologia IMAS. Hospital del Mar, Barcelona, Spain; 5 Lapeyronie Hospital, Montpellier, France; 6 Unit Rheumatology, Munich, Munich, Germany; 7 Hospital Santa Maria, Lisbon, Portugal; 8 Div Rheumatology, Univ. Firenze, Firenze, Italy; 9 Pierre Fabre, Castres, France; 10 Public Health Department – Pierre Fabre, Boulogne-billancourt, France

Tuesday, October 28, 9:00 AM – 11:00 AM. 1411/133

Career Interruptions and Sick Leaves among Fibromyalgia Patients

Harvey Moldofsky 1 , Katell LE LAY 2 , Sami Boussetta 2 , JP Caubère 3 , E. André 3 , Charles Taieb 2 . 1 Centre for Sleep and Chronobiology, Toronto, ON, Canada; 2 Pierre Fabre laboratories, Boulogne-billancourt, France; 3 Pierre Fabre laboratories, Castres, France

Tuesday, October 28, 9:00 AM – 11:00 AM. 1412/134

Fibromyalgia Moldofsky Questionnaire (FMQ): Validation of a Tool to Aid Diagnosis

Harvey Moldofsky 1 , Katell Le Lay 2 , Sami Boussetta 2 , Jean-Paul Caubere 3 , Etienne Andre 3 , Charles Taieb 2 . 1 Centre for Sleep and Chronobiology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; 2 Public Health department – Pierre Fabre, Boulogne-billancourt, France; 3 Pierre Fabre, Castres, France

Tuesday, October 28, 9:00 AM – 11:00 AM. 1413/135

Restorative effect of sleep: Validation of the SQA (Sleep Quality Assessment)

Charles TAIEB 1 , Sami BOUSSETTA 1 , Katell LE LAY 1 , Jean-Paul CAUBERE 2 , Etienne ANDRE 2 , Harvey MOLDOFSKY 3 . 1 Public Health Departement – Pierre Fabre laboratories, Boulogne-billancourt, France; 2 Pierre Fabre laboratories, Castres, France; 3 Centre for Sleep and Chronobiology, Toronto, ON, Canada

Tuesday, October 28, 9:00 AM – 11:00 AM. 1414/136

Pain Tolerance In Fibromyalgia

Robert S. Katz 1 , Sharon Ferbert 2 , Ben Small 3 , Susan Shott 1 . 1 Rush University Medical Center, Chicago, IL; 2 AFFTER (Advocates for Fibromyalgia Funding, Treatment, Education and Research, Chicago, IL; 3 Rush University Medical School, Chicago, IL

Tuesday, October 28, 9:00 AM – 11:00 AM. 1416/138

Exposure-Response Analyses of the Effects of Pregabalin in Patients with Fibromyalgia (FM) using Daily Pain Scores and Patient Global Impression of Change

Wonkyung Byon 1 , Marci Chew 1 , Kaori Ito 1 , Paula Burger 1 , Daniele Ouellet 2 , Lynne Pauer 2 , Bernhardt Zeiher 2 , Brian Corrigan 1 . 1 Pfizer, New London, CT; 2 Pfizer, Ann Arbor, MI

Tuesday, October 28, 9:00 AM – 11:00 AM. 1500/222

Presence of Physical and Psychosocial Symptoms in Adolescents with Juvenile Primary Fibromyalgia Syndrome (JPFS) in Comparison to Healthy Peers: A Follow-up Survey Study

Tracy V. Ting, Irina S. Parkins, Emily K. Verkamp, Anne M. Lynch-Jordan, T. Brent Graham, Susmita Kashikar-Zuck. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

Wednesday, October 29, 11:00 AM – 11:15 AM. 2095

Variation In Glutamate And Glutamine Levels Within The Anterior Insula Are Associated With Changes In Anxiety And Pain In Fibromyalgia (FM)

Richard E. Harris 1 , Pia C. Sundgren 2 , Eric Kirshenbaum 3 , Zhe Xiang 3 , Daniel J. Clauw 4 . 1 Department of Anesthesiology, University of Michigan, Ann Arbor, MI; 2 Departments of Radiology, University of Michigan, Ann Arbor, MI; 3 University of Michigan, Ann Arbor, MI; 4 Departments of Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI

Wednesday, October 29, 11:15 AM – 11:30 AM. 2096

Baseline Brain Activity in Fibromyalgia

Lori B. Siegel 1 , Zachery M. Rosengarten 2 , S. Ouyang 3 , H. Sun 3 , Cameron C. Leith 3 . 1 North Shore Rheumatology, Lake Forest, IL; 2 Rosalind Franklin University of Medicine and Science, North Chicago, IL; 3 Neurodynamics Research Institute, Bannockburn, IL

Wednesday, October 29, 11:45 AM – 12:00 PM. 2098

Toward the Development of Revised Criteria for the Fibromyalgia Diagnosis

Frederick Wolfe 1 , Daniel J. Clauw 2 , Don L. Goldenberg 3 , Robert S. Katz 4 . 1 National Data Bank for Rheumatic Diseases, Wichita, KS; 2 University of Michigan, Ann Arbor, MI; 3 Newton-Wellesley Hosp, Newton, MA; 4 Rush University Medical Center, Chicago, IL

Wednesday, October 29, 12:00 PM – 12:15 PM. 2099

Cytokine Levels in Fibromyalgia

Robert S. Katz, Rediet Kokebie. Rush University Medical Center, Chicago, IL

Wednesday, October 29, 12:15 PM – 12:30 PM. 2100

Alpha and Beta Adrenergic Receptors Polymorphisms and Fibromyalgia

Gilberto Vargas-Alarcon 1 , Manuel Martinez-Lavin 1 , Angelica Vargas 1 , Jose-Manuel Fragoso 1 , David Cruz-Robles 1 , Ferran Garcia-Fructuoso 2 , Jose-Ignacio Lao-Villadoniga 3 , Maite Vallejo 1 . 1 National Institute of Cardiology, Mexico City, Mexico; 2 CIMA Clinic, Barcelona, Spain; 3 Echevarne Laboratory, Barcelona, Spain

Sunday, October 26, 9:00 AM – 11:00 AM. 582/582

Milnacipran Improves Pain in Fibromyalgia Patients: Patient E-diary Results Over 15 Weeks in Two Randomized, Double-Blind, Placebo-Controlled Trials

Philip Mease 1 , Robert H. Palmer 2 , Peng Qu 2 , R. Michael Gendreau 3 , Rong Zablocki 3 . 1 Seattle Rheumatology Associates and Swedish Medical Center, Seattle, WA; 2 Forest Research Institute, Jersey City, NJ; 3 Cypress Bioscience, Inc., San Diego, CA

Sunday, October 26, 9:00 AM – 11:00 AM. 583/583

Improvements in Fibromyalgia Symptoms Are Sustained for 1 Year with Milnacipran Treatment: Results From a Dose-Controlled, Extension Study

Philip Mease 1 , Robert H. Palmer 2 , Srinivas Rao 3 , Rong Zablocki 3 , Peng Qu 2 . 1 Seattle Rheumatology Associates and Swedish Medical Center, Seattle, WA; 2 Forest Research Institute, Jersey City, NJ; 3 Cypress Bioscience, Inc., San Diego, CA

Sunday, October 26, 9:00 AM – 11:00 AM. 584/584

Milnacipran Improves Fatigue in Patients with Fibromyalgia: Results from Two Randomized, Double-Blind, Placebo-Controlled Trials

Daniel J. Clauw 1 , Robert H. Palmer 2 , Michael R. Hufford 3 , Rong Zablocki 3 , Yong Wang 2 . 1 Univeristy of Michigan, Ann Arbor, MI; 2 Forest Research Institute, Jersey City, NJ; 3 Cypress Bioscience, Inc., San Diego, CA

Sunday, October 26, 9:00 AM – 11:00 AM. 585/585

The Effect of Milnacipran Therapy on Body Weight and Body Mass Index in Two Randomized, Double-Blind, Placebo-Controlled Trials

Daniel J. Clauw 1 , Michael R. Hufford 2 , Rong Zablocki 2 , Peng Qu 3 , R. Michael Gendreau 2 , Robert H. Palmer 3 . 1 University of Michigan, Ann Arbor, MI; 2 Cypress Bioscience, Inc., San Diego, CA; 3 Forest Research Institute, Jersey City, NJ

Sunday, October 26, 9:00 AM – 11:00 AM. 586/586

The Beneficial Effect of Milnacipran on Fibromyalgia Syndrome is not Related with Antidepressant Properties: A European Multicenter, Double-Blind, Placebo-Controlled Trial

Jaime C. Branco 1 , Bjorn Bragee 2 , Olof Zachrisson 3 , Knut Mikkelsen 4 , Luis De Teresa 5 , Yves Mainguy 6 , Martine Galissie 7 , Stéphanie Lugardon 6 , Nicole Pezous 8 . 1 Hospital Egas Moniz, Lisboa, Portugal; 2 Smärtspecialistmottagningen, Stockholm, Sweden; 3 Gottfriesclinic AB, Mölndal, Sweden; 4 Revmatismesykehuset AS, Lillehammer, Norway; 5 Clínica Mediterranéa de Neurociencas, Aliacante, Spain; 6 Institut de Recherche Pierre Fabre, Labège, France; 7 Institut de Recherche Pierre Fabre, Labege, France; 8 Institut de Recherche Pierre-Fabre, Labège, France

Sunday, October 26, 9:00 AM – 11:00 AM. 587/587

Estimation of Minimum Clinically Important Difference of Pain in Fibromyalgia

Philip J. Mease 1 , Michael Spaeth 2 , Daniel J. Clauw 3 , Lesley M. Arnold 4 , Laurence A. Bradley 5 , I. J. Russell 6 , Daniel K. Kajdasz 7 , Daniel J. Walker 7 , Amy S. Chappell 7 . 1 Seattle Rheumatology Associate, Seattle, WA; 2 Practice for Internal Medicine/Rheumatology, Graefelfing, Germany; 3 University of Michigan Medical Center, Ann Arbor, MI; 4 University of Cincinnati College of Medicine, Cincinnati, OH; 5 University of Alabama at Birmingham, Birmingham, AL; 6 University of Texas Health Science Center at San Antonio, San Antonio, TX; 7 Lilly Research Laboratories, Indianapolis, IN

Sunday, October 26, 9:00 AM – 11:00 AM. 588/588

Impact of Duloxetine Treatment on Concentration and Mental Fatigue in Patients with Fibromyalgia

Daniel Clauw 1 , Ernest Choy 2 , Philip Mease 3 , Michael Spaeth 4 , Laurence Bradley 5 , I Jon Russsell 6 , Daniel Kajdasz 7 , Jonna Ahl 7 , Madelaine Wohlreich 7 . 1 University of Michigan Medical Center, Ann Arbor, MI; 2 King’s College London, London, United Kingdom; 3 University of Washington School of Medicine, Seattle, WA; 4 Practice for Internal Medicine / Rheumatology, Munich, Germany; 5 University of Alabama at Birmingham, Birmingham, AL; 6 University of Texas Health Science Center, San Antonio, TX; 7 Eli Lilly and Company, Indianapolis, IN

Sunday, October 26, 9:00 AM – 11:00 AM. 589/589

Dual Versus Mono Responders In Fibromyalgia Patients With Major Depressive Disorder

Daniel K. Kajdasz 1 , Lesley M. Arnold 2 , Adam Meyers 1 , Amy S. Chappell 1 , Deborah N. D’Souza 1 , Daniel J. Clauw 3 . 1 Lilly Research Laboratories, Indianapolis, IN; 2 University of Cincinnati College of Medicine, Cincinnati, OH; 3 University of Michigan, Ann Arbor, MI

Sunday, October 26, 9:00 AM – 11:00 AM. 590/590

Patients With Fibromyalgia: Baseline Observations From an International Randomized Controlled Trial (RCT) of Pregabalin (Lyrica ® )

Lynne Pauer 1 , Laurence Whelan 2 , Gary Atkinson 2 , Jeannette A. Barrett 3 , Teresa Leon 3 , Bernhardt G. Zeiher 1 . 1 Pfizer Global R&D, Ann Arbor, MI; 2 Pfizer Global R&D, Sandwich, United Kingdom; 3 Pfizer Global Pharmaceuticals, New York, NY

Sunday, October 26, 9:00 AM – 11:00 AM. 591/591

Is Pregabalin Better than Conventional Therapy in Fibromyalgia?

Micha Abeles, Aryeh M. Abeles. University of Connecticut School of Medicine, Farmington, CT

Sunday, October 26, 9:00 AM – 11:00 AM. 592/592

Pregabalin (Lyrica ® ) Monotherapy for Management of Fibromyalgia: Results From a 14-week Randomized, Double-blind, Placebo-controlled International Trial

Bernhardt G. Zeiher 1 , Gary Atkinson 2 , Lynne Pauer 1 , Laurence Whelan 2 . 1 Pfizer Global R&D, Ann Arbor, MI; 2 Pfizer Global R&D, Sandwich, United Kingdom

Sunday, October 26, 9:00 AM – 11:00 AM. 593/593

Do Fibromyalgia Patients Have A Genetic Predisposition To The Illness?

Robert S. Katz 1 , Sharon Ferbert 2 . 1 Rush University Medical Center, Chicago, IL; 2 AFFTER, Chicago, IL

Sunday, October 26, 9:00 AM – 11:00 AM. 594/594

Adverse Childhood Environment In Fibromyalgia Patients

Robert S. Katz 1 , Sharon Ferbert 2 , Alexandra Small 3 , Susan Shott 1 . 1 Rush University Medical Center, Chicago, IL; 2 AFFTER (Advocates for Fibromyalgia Funding, Treatment, Education and Research, Chicago, IL; 3 University of Illinois Medical School, Chicago, IL

Sunday, October 26, 9:00 AM – 11:00 AM. 595/595

Heart Rate Variability Is Not Superior To Classic Autonomic Testing In Patients With Fibromyalgia

Shin-Seok Lee, Hyun-Jung Yoon, Yong-Wook Park, Tae-Jong Kim. Chonnam National University Medical School, Gwangju, Republic of Korea

Sunday, October 26, 9:00 AM – 11:00 AM. 596/596

Transition from Chronic Axial Pain to Widespread Pain Over a Period of 5 Years: An Analysis of 320 Patients Seen in a Pain Clinic

Lindsay L. Kindler, Kim D. Jones, Nancy Perrin, Robert M. Bennett. Oregon Health & Sciences University, Portland, OR

Sunday, October 26, 9:00 AM – 11:00 AM. 597/597

Evidence of Abnormal Epidermal Nerve Fiber Density (ENFD) in Fibromyalgia

Xavier J. Caro, MD, FACR, Earl Winter, Ph.D.. Northridge Hospital Medical Center, Northridge, CA

Sunday, October 26, 9:00 AM – 11:00 AM. 598/598

Pathological Compulsive Behavior Associated with Dopamine Agonists Used to Treat Fibromyalgia

Andrew J. Holman. Pacific Rheumatology Research, Renton, WA

Sunday, October 26, 9:00 AM – 11:00 AM. 599/599

Autonomic Dysfunction in Fibromyalgia Assessed by the “Composite Autonomic Symptom Scale (COMPASS)”

Carla Solano 1 , Aline Martinez 1 , Lizbeth Becerril 1 , Angelica Vargas 1 , Javier Figueroa 1 , Carmen Navarro 2 , Cesar Ramos-Remus 3 , Manuel Martinez-Lavin 1 . 1 National Institute of Cardiology, Mexico City, Mexico; 2 National Institute of Respiratory Diseases, Mexico City, Mexico; 3 Centro Medico de Occidente, Guadalajara, Mexico

Sunday, October 26, 9:00 AM – 11:00 AM. 600/600

A Meta-analysis of Efficacy and Safety in the Treatment of Fibromyalgia

Neil Roskell 1 , Stephen Beard 1 , Ana Garcia-Cebrian 2 , Gerlinde Maas 3 , Trong Kim Le 4 . 1 RTI Health Solutions, Manchester, United Kingdom; 2 Eli Lilly, Windlesham, United Kingdom; 3 Boehringer Ingelheim GmbH, Ingelheim, Germany; 4 Eli Lilly, Indianapolis, IN

Sunday, October 26, 9:00 AM – 11:00 AM. 601/601

Does a Subnormal Stimulated Growth Hormone (GH) Response in Fibromyalgia Indicate GH Deficiency?

Atul A. Deodhar, Jessica Morea, Cheryl Hryciw, Kim D. Jones, Robert M. Bennett. Oregon Health & Science University, Portland, OR

Sunday, October 26, 9:00 AM – 11:00 AM. 602/602

The Efficacy of Periodic Acceleration and Craniosacral Massage for Treatment of Fibromyalgia

John T. Farrar, John T. Musser, Lan X. Chen. University of pennsylania, Philadelphia, PA

Sunday, October 26, 9:00 AM – 11:00 AM. 603/603

Improvement In Pain-related Symptoms Following A Multidisciplinay Treatment Programme In Fibromyalgia Patients:one Year Follow Up

Giovanni Biasi, Annalisa Suman, Marco Bonifazi, Barbara Biagi, Eleonora Prati, Giancarlo Carli, Mauro Galeazzi. University of Siena, siena, Italy

Sunday, October 26, 9:00 AM – 11:00 AM. 605/605

Exploration of Possible Relationships Between Pain and Mood: a Pooled Analysis of 3 Trials of Pregabalin (Lyrica ® ) as Treatment of Fibromyalgia

Lesley M. Arnold 1 , Lynne Pauer 2 , Ed Whalen 3 , Jeannette A. Barrett 3 , Teresa Leon 3 . 1 University of Cincinnati, Cincinnati, OH; 2 Pfizer Global R&D, Ann Arbor, MI; 3 Pfizer Global Pharmaceuticals, New York, NY

Sunday, October 26, 9:00 AM – 11:00 AM. 606/606

Milnacipran Reduces Fatigue in Patients with Fibromyalgia: Electronic Diary Results

Lesley M. Arnold 1 , Robert H. Palmer 2 , Michael R. Hufford 3 , Rong Zablocki 3 , Yong Wang 2 . 1 University of Cincinnati, Cincinnati, OH; 2 Forest Research Institute, Jersey City, NJ; 3 Cypress Bioscience, Inc., San Diego, CA

Sunday, October 26, 4:30 PM – 4:45 PM. 720

FMRI Evidence For Modulation of Pain by Milnacipran in Fibromyalgia

Frank Petzke 1 , Hanke Marcus 1 , Karolinska Institute, Karin Jensen 2 , Eva Kosek 2 , Martin Ingvar 2 , Ernest Choy 3 , Steven C R Williams 1 , Olivier Vitton 4 , Melanie Groc 4 , Yves Mainguy 4 , Richard H. Gracely 5 . 1 University Hospital of Cologne, Cologne, Germany; 2 Karolinska Institute, Stockholm, Sweden; 3 King’s College Hospital, London, United Kingdom; 4 Institut de Recherche Pierre Fabre, Labège, France; 5 University of Michigan, Ann Arbor, MI

Sunday, October 26, 4:45 PM – 5:00 PM. 721

An 8-week, Randomized, Double-blind, Placebo-controlled, Multi-center Study Of Esreboxetine Administered Once Daily In Patients With Fibromyalgia

Lesley Arnold 1 , Krai Chatamra 2 , Ian Hirsch 2 , Malcolm Stoker 2 . 1 University of Cincinnati College of Medicine, Cincinnati, OH; 2 Pfizer Inc, Sandwich, United Kingdom

Sunday, October 26, 5:00 PM – 5:15 PM. 722

Development of the Mental Clutter Scale

Robert S. Katz 1 , Serene Francis 2 , Frank Leavitt 1 . 1 Rush University Medical Center, Chicago, IL; 2 Lutheran General Hospital, Niles, IL

Sunday, October 26, 5:15 PM – 5:30 PM. 723

The Inability of Most US Patients to Tolerate the Recommended Doses of Pregabalin in the Treatment of FM

Daniel G. Arkfeld, Katy Setoodeh, J. Abrahim, Sarah E. Cole, Samy S. Metyas. University of Southern California, Keck School of Medicine, Los Angeles, CA

Sunday, October 26, 5:45 PM – 6:00 PM. 725

Societal Costs and Disability Impact in Rheumatic Diseases

Frederick Wolfe 1 , Kaleb Michaud 2 , Robert S. Katz 3 . 1 National Data Bank for Rheumatic Diseases, Wichita, KS; 2 University of Nebraska, Omaha, NE; 3 Rush University Medical Center, Chicago, IL

Friday, October 24, 11:30 AM – 1:00 PM. CRC01

Healthcare Provided By A Homeopath As An Adjunct To Usual Care For Fibromyalgia (fms): Results Of A Pilot Rct

clare relton, Esq. 1 , christine smith, Dr 2 , clare walters, Dr 3 , jackie raw 4 , Ade Adebajo, Dr 4 , Kate Thomas, Professor 5 . 1 University of Sheffield, Sheffield, United Kingdom; 2 Barnsley Hospital Research Department, Barnsley, United Kingdom; 3 Rheumatology, Barnsley Hospital NHSFT,, Barnsley, United Kingdom; 4 Rheumatology, Barnsley Hospital NHSFT, Barnsley, United Kingdom; 5 University of Leeds, Leeds, United Kingdom

Friday, October 24, 11:30 AM – 1:00 PM. CRC03

A New Model for Understanding Fibromyalgia Management Outcomes: A Pilot Study

Hazel L. Breland 1 , Margo B. Holm 2 , Joan C. Rogers 2 , Terence Starz 3 . 1 Medical University of South Carolina, Charleston, SC; 2 University of Pittsburgh, Pittsburgh, PA; 3 University of Pittsburgh Medical Center, Pittsburgh, PA

Monday, October 27, 9:00 AM – 11:00 AM. F28/482

Defective Hypothalamic Growth Hormone Response to Acute Exercise in Fibromyalgia is Associated with Elevated Serum Levels of IL-1a, IL-6, and IL-8

Rebecca L. Ross, K. D. Jones, R. M. Bennett, MD, L. J. Wood. Oregon Health & Science University, Portland, OR

American college of Rheumatology

Print Friendly, PDF & Email
Valora la información

Valora esta información

Comparte
0 comentarios

Dejar un comentario

¿Quieres unirte a la conversación?
Siéntete libre de contribuir

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.